Megan Dugger, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1913 Highway 394, Blountville, TN 37617 Phone: 423-662-7002 |
Mrs. Kristina Ann Roark, NP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 1913 Highway 394, Blountville, TN 37617 Phone: 423-662-7002 Fax: 423-662-7003 |
Ashley Brooke Booher, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1913 Highway 394 Ste 2, Blountville, TN 37617 Phone: 423-662-6002 |
Cori Baker, NP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 1913 Highway 394, Blountville, TN 37617 Phone: 423-662-7002 Fax: 423-662-7003 |
Ms. Jennifer Jane Williams, FNP Nurse Practitioner - Community Health Medicare: Not Enrolled in Medicare Practice Location: 154 Blountville Bypass, Blountville, TN 37617 Phone: 423-279-2638 Fax: 423-279-2727 |
Leslie Sullins, FNP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 1913 Highway 394, Blountville, TN 37617 Phone: 423-662-7002 |
Alicia D Frasure, FNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 154 Blountville Byp, Blountville, TN 37617 Phone: 423-279-2777 Fax: 423-279-2797 |
News Archive
A study led by researchers from Brigham and Women's Hospital suggests a new way to trace cancer back to its cell type of origin. By leveraging the epigenome maps produced by the Roadmap Epigenomics Program - a resource of data collected from over 100 cell types - the research team found that the unique genetic landscape of a particular tumor could be used to predict that tumor's cell type of origin.
Royal Philips Electronics today announced the enhanced iE33 xMATRIX cardiac ultrasound system featuring a new ergonomic solution for more efficient adult echocardiograms, the X5-1 transducer. With this enhanced technology, Philips continues its tradition of simplified, patient-focused healthcare solutions by providing a more complete imaging solution.
New findings from a landmark research study led by Scripps Health and the Scripps Translational Science Institute (STSI) reveal that personal genetic tests have some promising effects on consumers who choose to undergo the screenings. STSI is an initiative of Scripps Health in collaboration with The Scripps Research Institute.
Research led by a Johns Hopkins University biologist demonstrates the workings of a biochemical pathway that helps control glucose in the bloodstream, a development that could potentially lead to treatments for diabetes.
› Verified 3 days ago